ArticleDiscover oncology2025

Identification of the disulfidptosis-related key gene CD2AP as a potential biomarker and new therapeutic target for LUAD patients by comprehensive multi-omics analysis.

Zhiwu Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.